These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 17464246)

  • 1. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylator phenotypes in aging and cancer.
    Toyota M; Issa JP
    Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
    Matsubara N
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of genetic and epigenetic alterations in cancer.
    Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
    Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CpG island methylator phenotype is not associated with a personal or family history of cancer.
    Ward RL; Williams R; Law M; Hawkins NJ
    Cancer Res; 2004 Oct; 64(20):7618-21. PubMed ID: 15492290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
    Messick CA; Church J; Casey G; Kalady MF
    Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation and colorectal cancer.
    Jubb AM; Bell SM; Quirke P
    J Pathol; 2001 Sep; 195(1):111-34. PubMed ID: 11568897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of DNA hypermethylation in human neoplasia.
    Toyota M; Issa JP
    Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical application of targeting cancer through histone acetylation and hypomethylation.
    Gilbert J; Gore SD; Herman JG; Carducci MA
    Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.